DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR JUNIOR STRENGTH ADVIL

« Back to Dashboard

Clinical Trials for Junior Strength Advil

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00435500	Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children	Unknown status	Canadian Institutes of Health Research (CIHR)	Phase 3	The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years.
NCT00435500	Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children	Unknown status	The Hospital for Sick Children	Phase 3	The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years.
NCT00435500	Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children	Unknown status	University of Toronto	Phase 3	The purpose of this study is to determine whether semi-annual fluoride varnish applications combined with caregiver counseling are effective in preventing and reducing a severe form of dental decay, known as early childhood caries, in native and non-native children aged 6 months to 5 years.
NCT00931398	Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate	Withdrawn	Ortho-McNeil Janssen Scientific Affairs, LLC	Phase 4	The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl (Concerta) in college students with ADHD. This study will consist of 110 college students between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The study consists of an 8-week double-blind, placebo-controlled trial of placebo versus methylphenidate HCl (Concerta®) followed by a 10-week extension of open label methylphenidate HCl (Concerta®).

Clinical Trial Conditions for Junior Strength Advil

Condition Name

Condition Name for Junior Strength Advil
Intervention	Trials
Constipation	3
Venous Thromboembolism	2
Spinal-induced Hypotension	1
Gliomatosis Cerebri	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Junior Strength Advil
Intervention	Trials
Constipation	3
Venous Thromboembolism	2
Thromboembolism	2
Hemorrhage	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Junior Strength Advil

Trials by Country

Trials by Country for Junior Strength Advil
Location	Trials
United States	31
Germany	12
Austria	8
Italy	7
United Kingdom	7

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Junior Strength Advil
Location	Trials
Illinois	3
Pennsylvania	3
Georgia	3
Indiana	2
Florida	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Junior Strength Advil

Clinical Trial Phase

Clinical Trial Phase for Junior Strength Advil
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	4
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Junior Strength Advil
Clinical Trial Phase	Trials
Recruiting	8
Completed	4
Not yet recruiting	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Junior Strength Advil

Sponsor Name

Sponsor Name for Junior Strength Advil
Sponsor	Trials
Bayer	3
Bioforce AG	2
Janssen Research & Development, LLC	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Junior Strength Advil
Sponsor	Trials
Other	31
Industry	10

Export unavailable in trial.
Subscribe for complete access.